Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A functional SNP in the regulatory region of the decay-accelerating factor gene associates with extraocular muscle pareses in myasthenia gravis.

Autor: Heckmann, J. M.¹ jeanine.heckmann@uct.ac.za, Uwimpuhwe, H.^1,2, Ballo, R.^1,2, Kaur, M.³, Bajic, V. B.^3,4, Prince, S.²

Publikováno v: Genes & Immunity. Jan2010, Vol. 11 Issue 1, p1-10. 10p. 2 Charts, 3 Graphs.

Encephalopathy after persistent vomiting: Three cases of non-alcohol-related Wernicke's encephalopathy

Autor: Antel, K, Singh, N, Chisholm, B, Heckmann, J M

Publikováno v: SAMJ: South African Medical Journal, Volume: 105, Issue: 6, Pages: 442-443, Published: JUN 2015

Wernicke's encephalopathy (WE) is a medical emergency. Although WE is commonly viewed in the context of alcoholism, it can be caused by thiamine deficiency secondary to persistent vomiting. Non-alcohol-related WE may be more catastrophic in onset and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1575::cdf3c671cebd2fcba14363298456293e
http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742015000600011&lng=en&tlng=en

Neuropsychiatric symptoms in patients with thymoma-associated and non-thymoma myasthenia gravis

Autor: Freeman, C, Lewis, I G S, Heckmann, J M

Publikováno v: South African Journal of Psychiatry, Volume: 20, Issue: 2, Pages: 50-53, Published: JUN 2014
South African Journal of Psychiatry, Vol 20, Iss 2, Pp e1-e4 (2014)
South African Journal of Psychiatry

Background. Around 10 - 15% of patients with myasthenia gravis (MG) have a thymoma, and non-motor symptoms are more frequent in these patients. We hypothesised that neuropsychiatric symptoms would also be more frequent. Methods. A cross-sectional stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6508b6cd011333d0528df4acd9ee9e2b
http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S2078-67862014000200004&lng=en&tlng=en

Incidence of seropositive myasthenia gravis in Cape Town and South Africa

Autor: Kathleen Bateman, Schinkel, M., Little, F., Liebenberg, L., Vincent, A., Heckmann, J. M.

Publikováno v: South African Medical Journal; Vol 97, No 10 (2007): ; 956-962
Scopus-Elsevier

Background. Myasthenia gravis (MG) is a treatable autoimmune disease characterised by fatiguable weakness of skeletal muscles. More than 85% of MG patients have antibodies to the acetylcholine receptor (AChR) at the neuromuscular junction or are sero

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::46d0a82e9a868fb25d2ce8decfff252d
https://www.ajol.info/index.php/samj/article/view/13922